Fat Based Enteral Nutrition for Blood Glucose Control in ICU
NCT ID: NCT02584907
Last Updated: 2017-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2015-10-31
2017-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperglycemia in Patients with Stroke and Indication of Enteral Nutrition
NCT03422900
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients
NCT03003507
Does a Ketogenic Diet Causes Ketosis in Patients on Intensive Care?
NCT02763553
Starvation in the Treatment of Diabetic Ketoacidosis
NCT06186245
Intermittent vs Continuous Enteral Nutrition in Glycaemic Control of Diabetic ICU Patients
NCT07054476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Fat Enteral Nutrition
Diet in high fat group will be 20% from protein, 45% from fat and 35% from carbohydrate
High Fat Enteral Nutrition
Diet in high fat group will be 20% from protein, 45% from fat and 35% from carbohydrate
Standered Enteral Nutrition
Diet in standard group will be 20% from protein, 30% from fat and 50% from carbohydrate
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Fat Enteral Nutrition
Diet in high fat group will be 20% from protein, 45% from fat and 35% from carbohydrate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BS≥ 200mg/dl
* Without Renal and Liver Failure
* Without Hyperlipidemia and Nephrotic Syndrome
* Without Infection
* Without Obesity
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zahra Vahdat Shariatpanahi
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zahra Vahdat Shariatpanahi, MD, Ph.D
Role: STUDY_CHAIR
Faculty of Nutrition and Food Sciencees, Shahid Beheshti University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Nutrition Sciences and Food Technology
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wewalka M, Drolz A, Zauner C. Influence of fat-based versus glucose-based enteral nutrition formulas on glucose homeostasis. Crit Care. 2013; 17(Suppl 2): P250. Published online 2013 Mar 19. doi: 10.1186/cc12188. PMCID: PMC3642614.
Related Links
Access external resources that provide additional context or updates about the study.
Critical Care
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1395/34199
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.